Department of Internal Medicine, Japan Community Healthcare Organization Tokyo Takanawa Hospital.
Department of Gastroenterology, Tokyo Teishin Hospital, Tokyo, Japan.
Eur J Gastroenterol Hepatol. 2024 Dec 1;36(12):1399-1403. doi: 10.1097/MEG.0000000000002846. Epub 2024 Sep 26.
The objective of this study is to clarify the clinical features of thyroid dysfunction observed in patients with autoimmune pancreatitis (AIP).
We repeatedly examined thyroid function in 74 patients with type 1 AIP (58 males, 16 females; average onset age of AIP 67 years). Clinical and serological findings in patients with thyroid dysfunction were analyzed.
During follow-up, clinical and subclinical hypothyroidism were observed in 3 and 17 patients, respectively. Clinical and subclinical hyperthyroidism were observed in 5 and 1 patients, respectively. One patient showed clinical hyperthyroidism followed by subclinical hypothyroidism. All patients with clinical and subclinical hypothyroidism were asymptomatic and required no medical treatment, whereas four patients with clinical hyperthyroidism were symptomatic and received treatment with thiamazole.
Frequent hypothyroidism in AIP, which was previously reported, was confirmed. Moreover, in this study, the association between hyperthyroidism and AIP was demonstrated. Hyperthyroidism in AIP may be more clinically significant than hypothyroidism because patients frequently require medical treatment.
本研究旨在阐明自身免疫性胰腺炎(AIP)患者甲状腺功能障碍的临床特征。
我们对 74 例 1 型 AIP 患者(58 名男性,16 名女性;AIP 的平均发病年龄为 67 岁)进行了甲状腺功能的反复检查。分析了甲状腺功能障碍患者的临床和血清学发现。
在随访期间,分别观察到 3 例和 17 例临床和亚临床甲状腺功能减退症。分别观察到 5 例和 1 例临床和亚临床甲状腺功能亢进症。1 例患者表现为临床甲状腺功能亢进症,随后出现亚临床甲状腺功能减退症。所有临床和亚临床甲状腺功能减退症患者均无症状,无需治疗,而 4 例临床甲状腺功能亢进症患者出现症状,接受了他巴唑治疗。
证实了先前报道的 AIP 中频繁发生的甲状腺功能减退症。此外,本研究还表明了甲状腺功能亢进症与 AIP 之间的关联。与甲状腺功能减退症相比,AIP 中的甲状腺功能亢进症可能更具临床意义,因为患者经常需要治疗。